CRISPR-based screening pinpoints H2AZ1 as a driver of senescence in human mesenchymal stem cells
1. State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
2. State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
3. Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
4. CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing 100101, China
5. University of Chinese Academy of Sciences, Beijing 100049, China
6. Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China
7. Beijing Institute for Stem Cell and Regenerative Medicine, Beijing 100101, China
8. Advanced Innovation Center for Human Brain Protection and National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital Capital Medical University, Beijing 100053, China
9. Aging Translational Medicine Center, International Center for Aging and Cancer, Beijing Municipal Geriatric Medical Research Center, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
10. International Center for Aging and Cancer, Hainan Academy of Medical Sciences, Hainan Medical University, Haikou 571199, China
11. Aging Biomarker Consortium, Beijing 100101, China
12. Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China
ghliu@ioz.ac.cn (G.-H. Liu)
zhangwq@big.ac.cn (W. Zhang)
sunshuhui327@163.com (S. Sun)
qujing@ioz.ac.cn (J. Qu)
Show less